|
Conformed Copy
SECURITIES PURCHASE AGREEMENT (CONVERTIBLE
DEBENTURES)
THIS SECURITIES PURCHASE AGREEMENT
(the “Agreement”), dated as of March 28,
2005, is entered into by and among Eye
Care International, Inc. , a Delaware
corporation (the “Company”), having its address at 1511
North Westshore Boulevard, Suite 925, Tampa, Florida 33607, and
each entity named on the signature page hereto as a buyer and the
permitted assigns of such entity (each, a “Buyer”)
(each agreement with a Buyer being deemed a separate and
independent agreement between the Company and such Buyer, except
that each Buyer acknowledges and consents to the rights granted to
each other Buyer under this Agreement and the Transaction Documents
(as defined below)).
W I T N E S S E T H:
WHEREAS , the Company
and the Buyers are executing and delivering this Agreement in
accordance with and in reliance upon the exemption from securities
registration afforded, inter
alia , by Rule 506 under Regulation D
(“Regulation D”) as promulgated by the United States
Securities and Exchange Commission (the “SEC”) under
the Securities Act of 1933, as amended (the “1933
Act”), and/or Section 4(2) of the 1933 Act; and
WHEREAS, the Buyers
severally, and not jointly, wish to purchase, upon the terms and
subject to the conditions of this Agreement, a minimum aggregate
amount of $250,000 and a maximum aggregate amount of $1,000,000 of
convertible debentures of the Company (the
“Debentures”), which will be convertible into shares of
the Company’s Class A Common Stock, par value $0.001 per
share (the “Common Stock”), upon the terms and subject
to the conditions of the Debentures, and subject to acceptance of
this Agreement by the Company;
NOW THEREFORE , in
consideration of the premises and the mutual covenants contained
herein and other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the parties agree as
follows:
|
1.
|
AGREEMENT TO PURCHASE; PURCHASE
PRICE.
|
|
|
|
|
|
a.
Purchase
(i) The
undersigned Buyers hereby severally agree to purchase the
Debentures from the Company on the terms and conditions set forth
below in this Agreement and the other Transaction Documents (as
defined below).
(ii) Subject
to the terms and conditions of this Agreement and the other
Transaction Documents the Buyers will purchase the Debentures at
one or more closings (each, a “Closing”) to be held on
the respective Closing Dates (as defined below).
(iii) The
purchase price to be paid respectively by the Buyers shall equal
100% of the face amount of the Debentures being purchased on the
Closing Date by each Buyer as set forth on the signature page to
this Agreement.
b.
Certain Definitions. As
used herein, each of the following terms has the meaning set forth
below, unless the context otherwise requires:
(i) “Affiliate”
means, with respect to a specific Person referred to in the
relevant provision, another Person who or which controls or is
controlled by or is under common control with such specified
Person.
(ii) “Certificates”
means the relevant Debentures duly executed on behalf of the
Company and issued in the name of the respective Buyer.
(iii) “Closing
Date” means the respective dates on which the Closings
referred to in this Agreement are held.
(iv) “Conversion
Shares” means the shares of Common Stock issuable upon
conversion of the Debentures.
(v) “Effective
Date” means the effective date of the Registration Statement
covering the Registrable Securities (as those terms are defined in
the Registration Rights Agreement defined below) for the Debentures
issued on the Closing Date.
(vi) “Escrow”
means the Divine Capital Markets LLC EYCI Special Escrow Account
maintained at JP Morgan / Chase Manhattan Bank.
(vii) “Final
Closing Date” shall have the meaning ascribed to such term in
Section 6(d).
(viii) “Person”
means any living person or any entity, such as, but not necessarily
limited to, a corporation, partnership or trust.
|
(ix)
|
“Placement Agent” means Divine Capital
Markets, LLC.
|
|
|
(x)
|
“Purchase Price” means the purchase
price for the Debentures.
|
|
(xi)
|
“Securities” means the Debentures and
Conversion Shares.
|
|
|
|
|
|
(xii) “Shares”
means the Conversion Shares and the shares issued to the Placement
Agent or any of its designees in connection with its services in
connection with this offering of Debentures.
c.
Form of Payment; Delivery of Certificates. Each of the
Buyers shall pay the Purchase Price for the Debentures to be
purchased by such Buyer by delivering immediately available good
funds in United States Dollars to the Escrow prior to the
respective Closing on the applicable Closing Date, determined as
provided in Section 6.
(ii) Promptly
following payment to the Company from the Escrow of the Purchase
Price to be paid for the purchase of the Debentures being purchased
by such Buyer, the Company shall deliver to the Buyers the
Certificates purchased at such Closing.
2
d.
Payment to the Escrow. All payments to
the Escrow for the purchase of the Debentures shall be made at or
prior to the Closing by wire transfer of funds to the Escrow, as
follows:
| Beneficiary Account
Name: |
Divine Capital Markets
LLC |
| |
EYCI Special Escrow
Account |
| |
|
|
Beneficiary Account No.:
|
217-633 623 1-65
|
| |
|
| FBO: EYCI, Special
Account for Exclusive Benefit of Clients of DCM |
| |
|
| ABA/Transit No.: |
021-000-021 |
| |
|
| Beneficiary Bank: |
JP Morgan / Chase Manhattan
Bank |
| |
1 Chase Manhattan Plaza |
| |
New York, New York
10004 |
2. BUYERS REPRESENTATIONS, WARRANTIES, ETC.; ACCESS TO
INFORMATION; INDEPENDENT INVESTIGATION.
Each Buyer represents and warrants to, and covenants
and agrees with, the Company as follows:
a. Without limiting any
Buyer’s right to sell the Common Stock pursuant to the
Registration Statement, each Buyer is purchasing the Debentures and
will be acquiring the Conversion Shares for its own account for
investment only and not with a view towards the public sale or
distribution thereof and not with a view to or for sale in
connection with any distribution thereof.
b. Each Buyer is (i) an
“accredited investor” as that term is defined in Rule
501 of the General Rules and Regulations under the 1933 Act by
reason of Rule 501(a)(3), (ii) experienced in making investments of
the kind described in this Agreement and the related documents,
(iii) able, by reason of the business and financial experience of
its officers (if an entity) and professional advisors (who are not
affiliated with or compensated in any way by the Company or any of
its affiliates or selling agents), to protect its own interests in
connection with the transactions described in this Agreement, and
the related documents, and (iv) able to afford the entire loss of
its investment in the Securities.
c. All subsequent offers and
sales of the Securities by each Buyer shall be made pursuant to
registration of the Shares under the 1933 Act or pursuant to an
exemption from registration and compliance with applicable
states’ securities laws.
d. Each Buyer understands
that the Securities are being offered and sold to it in reliance on
specific exemptions from the registration requirements of United
States federal and state securities laws and that the Company is
relying upon the truth and accuracy of, and the Buyer’s
compliance with, the representations, warranties, agreements,
acknowledgments and understandings of the Buyers set forth herein
in order to determine the availability of such exemptions and the
eligibility of the Buyers to acquire the Securities.
3
e. Each Buyer and its
advisors, if any, have been furnished with all materials relating
to the business, finances and operations of the Company and
materials relating to theoffer and sale of the Securities which
have been requested by the Buyer. Each Buyer and its advisors, if
any, have been afforded the opportunity to ask questions of the
Company and have received complete and satisfactory answers to any
such inquiries. Without limiting the generality of the foregoing,
each Buyer has also had the opportunity to obtain and to review the
Company’s (1) Annual Report on Form 10-KSB for the fiscal
year ended December 31, 2003, filed April 28, 2004, (2) Quarterly
Report on Form 10-QSB for the period ended March 31, 2004 filed May
24, 2004, (3) Quarterly Report on Form 10-QSB for the period ended
June 30, 2004 filed September 8, 2004, (4) Amendment to Quarterly
Report on Form 10-QSB for the period ended June 30, 2004 filed
October 19, 2004, (5) Quarterly Report on Form 10-QSB for the
period ended September 30, 2004 filed November 23, 2004 and (6)
Registration Statement on Form SB-2/A filed February 10, 2005 (the
“Pending SB-2” and together with the other documents
referred to in the preceding clauses (1) through (5), the
“Company’s SEC Documents”).
f. Each Buyer
understands that its investment in the Securities involves a high
degree of risk, including the risk of the loss of the Buyer’s
entire investment.
g. Each Buyer understands
that no United States federal or state agency or any other
government or governmental agency has passed on or made any
recommendation or endorsement of the Securities.
h. Each Buyer is duly
organized, validly existing and in good standing under the laws of
the jurisdiction of its organization. This Agreement and the other
Transaction Documents have been duly and validly authorized,
executed and delivered on behalf of the Buyer and create a valid
and binding agreement of the Buyer enforceable in accordance with
its terms, subject as to enforceability to general principles of
equity and to bankruptcy, insolvency, moratorium and other similar
laws affecting the enforcement of creditors’ rights
generally.
i. Such Buyer has not
employed any broker or finder in connection with the transactions
contemplated by this Agreement.
j. The state in which
any offer to purchase shares hereunder was made to or accepted by
such Buyer is the state shown as the Buyer’s address on
Schedule I hereto.
k. Each Buyer was not formed
for the purpose of investing solely in the Securities which may be
acquired hereunder.
l. Each Buyer is able
to bear the complete loss of such Buyer’s investment in the
Securities.
m. Each Buyer’s execution,
delivery and performance under this Agreement will not breach the
provisions of any agreement to which such Buyer is a
party.
4
3. COMPANY REPRESENTATIONS, ETC. The
Company represents and warrants to the Buyers that:
a. Concerning the Debentures and the Shares.
There are no preemptive rights of any stockholder of
the Company to acquire the Debentures or the Shares.
b. Reporting Company Status. The Company
is a corporation duly organized, validly existing and in good
standing under the laws of the State of Delaware and has the
requisite corporate power to own its properties and to carry on its
business as now being conducted. The Company is duly qualified as a
foreign corporation to do business and is in good standing in the
State of Florida and in each other jurisdiction where the nature of
the business conducted or property owned by it makes such
qualification necessary, other than those jurisdictions in which
the failure to so qualify would not have a material adverse effect
on the business, operations or condition (financial or otherwise)
or results of operation of the Company and its subsidiaries taken
as a whole (a “Material Adverse Effect”). The Company
has registered its Common Stock pursuant to Section 12 of the
Securities Exchange Act of 1934, as amended (the “1934
Act”), and the Common Stock is listed and traded on the OTC
Bulletin Board Market of the National Association of Securities
Dealers, Inc. (trading symbol: EYCI). The Company has received no
notice, either oral or written, with respect to the continued
eligibility of the Common Stock for such listing, and the Company
has maintained all requirements for the continuation of such
listing.
c. Authorized Shares. The authorized
capital stock of the Company consists of 120,000,000 shares of
capital stock, of which 80,000,000 shares are designated as Class A
Common Stock, par value $0.001 per share (the “Common
Stock”), 20,000,000 shares are designated Class B Common
Stock, par value $0.001 per share and 20,000,000 shares are
designated as Preferred Stock. As of the date hereof, assuming the
conversion or exercise of certain currently outstanding common
stock equivalents of the Company into underlying shares of Common
Stock, 23,807,147 shares of Common Stock (excluding an additional
approximately 2,676,344 shares of Common Stock to be issued upon
conversion of certain currently outstanding debentures and exercise
of certain currently outstanding warrants), 5,302,802 shares of
Class B Common Stock and 155 Series A Convertible Preferred Shares
and 86 Series C Mandatory Convertible Preferred Shares of stock are
issued and outstanding. All issued and outstanding shares of Common
Stock have been duly authorized and validly issued and are fully
paid and nonassessable. The Company has sufficient authorized and
unissued shares of Common Stock as may be necessary to effect the
issuance of the Shares. The Shares have been duly authorized and,
when issued upon conversion of, or as interest on, the Debentures
will be duly and validly issued, fully paid and non-assessable and
will not subject the holder thereof to personal liability by reason
of being such holder. At all times, the Issuer shall keep available
and reserved for issuance to the holders of the Debentures Common
Stock duly authorized for issuance against the
Debentures.
d. Securities Purchase Agreement; Registration Rights
Agreement. This Agreement and the
Registration Rights Agreement, between the Company and the Buyers,
substantially in the form of Exhibit C annexed hereto (the
“Registration Rights Agreement”), and the transactions
contemplated thereby, have been duly and validly authorized by the
Company, this Agreement has been duly executed and delivered by the
Company. Each of this Agreement, the Debentures and the
Registration Rights Agreement, when executed and delivered by the
Company, are and will be, valid, legal and binding agreements of
the Company enforceable in accordance with their respective terms,
subject as to enforceability to general principles of equity and to
bankruptcy, insolvency, moratorium, and other similar laws
affecting the enforcement of creditors’ rights
generally.
5
e. Non-contravention. The execution and
delivery of this Agreement, the Debentures and the Registration
Rights Agreement by the Company, the issuance of the Securities,
and the consummation by the Company of the other transactions
contemplated by this Agreement, the Registration Rights Agreement,
and the Debentures do not and will not conflict with or result in a
breach by the Company of any of the terms or provisions of, or
constitute a default under (i) the Certificate of Incorporation or
by-laws of the Company, each as currently in effect, (ii) any
indenture, mortgage, deed of trust, or other material agreement or
instrument to which the Company is a party or by which it or any of
its properties or assets are bound, including any listing agreement
for the Common Stock, except as herein set forth or an event which
results in the creation of any lien, charge or encumbrance upon any
assets of the Company or of any of its subsidiaries or the
triggering of any preemptive or anti-dilution rights or rights of
first refusal or first offer on the part of holders of the
Company’s securities, (iii) to its knowledge, any existing
applicable law, rule, or regulation or any applicable decree,
judgment, or order of any court, United States federal or state
regulatory body, administrative agency, or other governmental body
having jurisdiction over the Company or any of its properties or
assets, or (iv) the Company’s listing agreement for its
Common Stock, except such conflict, breach or default which would
not have a Material Adverse Effect.
f.
Approvals. No
authorization, approval or consent of any court, governmental body,
regulatory agency, self-regulatory organization, or stock exchange
or market or the stockholders of the Company is required to be
obtained by the Company for the issuance and sale of the Securities
to the Buyers as contemplated by this Agreement, except such
authorizations, approvals and consents that have been obtained, or
such authorizations, approvals and consents, the failure of which
to obtain would not have a Material Adverse Affect.
g. SEC Filings. To the best of the
Company's knowledge, none of the Company’s SEC Documents
contained, at the time they were filed, any untrue statement of a
material fact or omitted to state any material fact required to be
stated therein or necessary to make the statements made therein in
light of the circumstances under which they were made, not
misleading. Except as set forth on Schedule 3(g) to this Agreement, the
Company has since January 1, 2003 timely filed all requisite forms,
reports and exhibits thereto with the SEC. The Company is not aware
of any event occurring on or prior to a Closing Date or the
Delivery Date (other than the transactions effected hereby) that
would require the filing of, or with respect to which the Company
intends to file, a Form 8-K after such date.
h. Absence of Certain Changes. Since
December 31, 2003, there has been no material adverse change and no
material adverse development in the business, properties,
operations, condition (financial or otherwise), or results of
operations of the Company or any of its subsidiaries, except as
disclosed in the Company’s SEC Documents. Since December 31,
2003, except as provided in the Company’s SEC Documents,
neither the Company nor any of its subsidiaries has (i) incurred or
become subject to any material liabilities (absolute or contingent)
except liabilities incurred in the ordinary course of business
consistent with past practices; (ii) discharged or satisfied any
material lien or encumbrance or paid any material obligation or
liability (absolute or contingent), other than current liabilities
paid in the ordinary course of business consistent with past
practices; (iii) declared or made any payment or distribution of
cash or other property to stockholders with respect to its capital
stock, or purchased or redeemed, or made any agreements to purchase
or redeem, any shares of its capital stock; (iv) sold, assigned or
transferred any other tangible assets, or canceled any debts or
claims, except in the ordinary
6
course of business consistent with past practices;
(v) suffered any substantial losses or waived any rights of
material value, whether or not in the ordinary course of business,
or suffered the loss of any material amount of existing business;
(vi) made any changes in employee compensation, except in the
ordinary course of business consistent with past practices; or
(vii) experienced any material problems with labor or management in
connection with the terms and conditions of their
employment.
i.
Full Disclosure. There
is no fact known to the Company (other than general economic
conditions known to the public generally or as disclosed in the
Company’s SEC Documents) that has not been disclosed in
writing to the Buyers that (i) would reasonably be expected to have
a Material Adverse Effect, (ii) would reasonably be expected to
materially and adversely affect the ability of the Company to
perform its obligations pursuant to this Agreement or any of the
agreements contemplated hereby (collectively, including this
Agreement, the “Transaction Documents”), or (iii) would
reasonably be expected to materially and adversely affect the value
of the rights granted to the Buyers in the Transaction
Documents.
j.
Absence of Litigation. There is no action, suit, proceeding, inquiry or investigation
before or by any court, public board or body pending or, to the
knowledge of the Company, threatened against or affecting the
Company or any of its subsidiaries, wherein an unfavorable
decision, ruling or finding would have a Material Adverse Effect or
which would adversely affect the validity or enforceability of, or
the authority or ability of the Company and its subsidiaries taken
as a whole to perform its obligations under, any of the Transaction
Documents. Neither the Company nor any of its subsidiaries is a
party to or subject to the provisions of, any order, writ,
injunction, judgement or decree of any court or government agency
or instrumentality which could reasonably be expected to have a
Material Adverse Effect.
k. Absence of Events of Default. Except
as disclosed in the Company’s SEC Documents, no Event of
Default (or its equivalent term), as defined in the respective
agreement, indenture, mortgage, deed of trust or other instrument
to which the Company or any of its subsidiaries is a party, and no
event which, with the giving of notice or the passage of time or
both, would become an Event of Default (or its equivalent term) (as
so defined in such document), has occurred and is continuing, which
would have a Material Adverse Effect.
l.
Prior Issues. Except as set forth in the
Company’s SEC Documents, during the twelve (12) months
preceding the date hereof, the Company has not issued any
convertible securities or any shares of the Common
Stock.
m. No
Undisclosed Liabilities or Events
|